Clinical Trial Update: Pentoxifylline for the Prevention of PEP [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating pentoxifylline to prevent post-ERCP pancreatitis (PEP) in patients with pancreatitis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Pancreatitis | EARLY_Phase 1 | Status: UNKNOWN